arrow
M

Moherndran Archary

africa health research institute
H指数:29
被引数:3,320

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Understanding Adolescent Anti-Retroviral Therapy Use in the BREATHER-Plus Trial: Qualitative Findings From South Africa and Uganda

理解BREATHER-Plus试验中青少年抗逆转录病毒疗法的使用:来自南非和乌干达的定性研究结果

2026-09-230
OAAI
Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial

非洲住院的重症社区获得性肺炎儿童中抗生素治疗的逐步减量、最佳用药及总疗程(PediCAP):一项析因随机对照试验

2026-07-230
OAAI
Now, I have no fear: aqualitative assessment of the interactive transition support for adolescents living with HIV in South Africa virtual vs. in-person (inTSHA VIP) intervention

我现在无所畏惧:南非生活于HIV中的青少年在虚拟与面对面干预(inTSHA VIP)中互动过渡支持的定性评估

2026-05-010
PRE
Impact of co-amoxiclav versus amoxicillin on the gastrointestinal microbiota in sub-Saharan children hospitalized with pneumonia

在撒哈拉以南非洲因肺炎住院的儿童中,阿莫西林克拉维酸钾与阿莫西林对胃肠道微生物群的影响

2026-05-010
PRE
Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial

每日一次的达芦那韦/拉米夫定固定剂量制剂在HIV感染者儿童中的应用:一项在开放标签、多中心、随机、非劣效性D3/PENTA 21试验中嵌套的药代动力学和安全性的子研究

2025-09-260
PREAI
Pharmacokinetics of long-acting cabotegravir and rilpivirine in virologically suppressed adolescents living with HIV-1 in Sub-Saharan Africa: Data from the LATA trial

长效卡博格韦和 rilpivirine 在病毒学抑制的撒哈拉以南非洲 HIV-1 感染青少年中的药代动力学:来自 LATA 试验的数据

2025-09-030
PREAI
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M™ adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial
2024-12-120
OAAI
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium
2024-10-011
PRE
Influence of age and co-medication on dolutegravir glucuronidation in paediatric patients
2024-09-030
OA
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission
2024-06-063
OAAI
Navigating the COVID-19 pandemic for participant recruitment and follow-up: experiences from the PediCAP clinical trial consortium
2023-12-170
OA
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
2023-01-2128
OAAI